Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Schwetz to lead OHRP: Bernard Schwetz, PhD/DVM, is named permanent director of the HHS Office for Human Research Protections April 8, after serving in an acting capacity since February 2003. The former FDA senior adviser plans to work toward developing better communications with the public as well as with the human subjects research community. Schwetz also will try to provide more OHRP guidance on the interpretation of HHS regulations. At the most recent meeting of the Secretary's Advisory Committee on Human Research Protections, for which he is executive secretary, Schwetz agreed with panel members that OHRP and FDA should develop official guidance on research adverse event reporting...

You may also be interested in...



Aspect Medical Eyes Profitability Through BIS Extension, OEM Integration

The recent approval of Aspect Medical's BISx integration technology is a "critical step" in the firm's efforts to "BIS-enable" future patient monitoring systems introduced to the U.S. market, President & CEO Nassib Chamoun told analysts April 22

Aspect Medical Eyes Profitability Through BIS Extension, OEM Integration

The recent approval of Aspect Medical's BISx integration technology is a "critical step" in the firm's efforts to "BIS-enable" future patient monitoring systems introduced to the U.S. market, President & CEO Nassib Chamoun told analysts April 22

CDRH Leadership Changes May Be Imminent; NCI’s Ellen Feigal To Leave Institute

FDA is vetting a list of more than 20 candidates for a CDRH clinical deputy spot - a position that may grow in stature with the potential departure of Director David Feigal

Related Content

UsernamePublicRestriction

Register

MT020061

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel